subject area of
- Asymmetries in the spatial distributions of enhancing lesions and black holes in relapsing-remitting ms Academic Article
- Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation Academic Article
- Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis Academic Article
- New hypointense lesions on mri in relapsing-remitting multiple sclerosis patients Academic Article
- Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study Academic Article
- Predictive value of lesions for relapses in relapsing-remitting multiple sclerosis Academic Article
- Seasonal variations in exacerbations and mri parameters in relapsing-remitting multiple sclerosis Academic Article
- Sphingosine 1-phosphate receptor agonists: A patent review (2010 - 2012) Academic Article